We believe in research partnerships. Our research partners include clinicians, biomedical and other researchers, engineers, industry and government, and most importantly patients. CANet capitalizes on advances in computing power, internet-based communication, and accessible data to improve arrhythmia related knowledge and care.
With more than 150 investigators across Canada, our Network conducts research under three broad themes.
Programs and projects cut across themes, bringing multi-sectoral and multidisciplinary perspectives to bear on these challenges. CANet provides the biotechnology industry with opportunities to develop, test and market new technologies and therapies for the diagnosis and treatment of arrhythmias. Research from our Network has a significant impact on health and wealth creation in Canada.
From governance to research to disease management, patients are co-leaders in our Network.
We ensure patient partnership, involvement, and acceptability throughout the research cycle; from conception to execution, to implementation and evaluation, lead to outcomes allowing patients to co-manage their arrhythmia disorders and help produce both economic and social benefits for Canada.
Throughout the network, patients are actively engaged and empowered to identify the unmet needs in each of CANet’s priority areas. Our research programs are co-developed to provide real clinical, social and economic benefit.
There is an unprecedented opportunity to evaluate the impact of patient involvement on Network operations and outcomes, and in doing so, our Network adds to the growing science on patient engagement providing evidence for future public policy development in health care delivery and innovation.
To learn more about our work with engaging patients, click here.